has role has functional parent metabolite lividomycins lividomycin A (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-{[alpha-D-mannopyranosyl-(1->4)-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy}cyclohexyl 2-amino-2,3-dideoxy-alpha-D-ribo-hexopyranoside 761.354 761.76970 A member of the class of lividomycins that is lividomycin B in which position 4 of the diamino-L-idopyranosyl moiety has been converted to its alpha-D-mannopyranoside. C29H55N5O18 CAS:36441-41-5 CHEBI:71961 DBLVDAUGBTYDFR-SWMBIRFSSA-N DrugBank:DB04728 InChI=1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1 KEGG:C17707 MetaCyc:CPD-14175 NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O O-2-amino-2,3-dideoxy-alpha-D-ribo-hexopyranosyl-(1-4)-O-(O-alpha-D-mannopyranosyl-(1-4)-O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-D-streptamine PDBeChem:LIV PMID:1047630 PMID:1052072 PMID:4142798 PMID:4203572 PMID:4215906 PMID:4364938 PMID:4945812 PMID:5034809 PMID:5092786 PMID:779697 Reaxys:6763509 SF 767 A Wikipedia:Lividomycin antibiotic 503-2 antibiotic SF 767 A chebi_ontology lividomicina lividomycin lividomycine lividomycinum mannosyldeoxyparomomycin quintomycin B lividomycin B paromomycin